Lavo AI

Lavo Life Sciences is a startup that aims to revolutionize drug development with AI-accelerated chemistry simulations. Their technology can help pharmaceutical companies bring new therapies to patients faster and cheaper by predicting the crystal structure of drug molecules, which can affect their stability, solubility, bioavailability, and patentability. The company has developed a novel approach to crystal structure prediction (CSP) that leverages AI and cloud computing to make it faster and more robust. Their software uses custom force fields for each target molecule, which are optimized using machine learning techniques. This approach is as accurate as traditional quantum chemistry methods such as density functional theory (DFT) but is 100 times faster. By using Lavo Life Sciences' software, pharmaceutical companies can reduce the time and cost of CSP from weeks or months to hours or days. This can help them discover new polymorphs, optimize drug properties, avoid patent infringement, and accelerate drug development. The company is currently working with several leading pharmaceutical companies to apply their technology to real-world problems. If you are interested in learning more about Lavo Life Sciences and how their AI-accelerated chemistry simulations can help you with your drug development challenges, please contact them at [email protected].